180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Operating Expenses | 4,804 | 5,640 | 4,055 | 4,522 | 3,681 |
Operating Income | -4,804 | -5,640 | -4,055 | -4,522 | -3,681 |
Interest Expense | 12 | 5 | 9 | 9 | 7 |
Other Income | 53 | -17,041 | -17,423 | 7,470 | 5,252 |
Pre-tax Income | -4,762 | -22,685 | -21,487 | 2,939 | 1,564 |
Net Income Continuous | -4,762 | -21,742 | -21,487 | 2,939 | 1,564 |
Net Income | $-4,762 | $-21,742 | $-21,487 | $2,939 | $1,564 |
EPS Basic Total Ops | -24.15 | -228.82 | -208.56 | 32.70 | 17.49 |
EPS Basic Continuous Ops | -24.17 | -228.95 | -208.52 | 32.75 | 17.46 |
EPS Diluted Total Ops | -24.15 | -228.82 | -208.56 | 32.70 | 17.49 |
EPS Diluted Continuous Ops | -24.17 | -228.95 | -208.52 | 32.75 | 17.46 |
EPS Diluted Before Non-Recurring Items | -24.14 | N/A | -26.62 | N/A | N/A |
EBITDA(a) | $-4,225 | $9,703 | $15,437 | $-3,690 | $-3,058 |